Vcaps Plus Capsules

Vcaps Plus Capsules
Product Description

Vcaps® Plus capsules developed without gelling agents provide HPMC capsules with improved physical and operational features to match the needs of the pharmaceutical industry.  A new in-vivo study demonstrates that Vcaps Plus capsules are equivalent to gelatin in terms of human pharmacokinetics profile, making them an excellent alternative to gelatin or traditional hypromellose (HPMC) for optimizing delivery, performance and stability of OTC, NCEs and off-patent products.

Lonza (Thailand) Co., Ltd.

  • TH
  • 2018
    On CPHI since
Specifications

Lonza (Thailand) Co., Ltd.

  • TH
  • 2018
    On CPHI since

More Products from Lonza (Thailand) Co., Ltd. (2)

  • CAPSUGEL® ZEPHYR™

    Product CAPSUGEL® ZEPHYR™

    Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI devices are a simple and cost-effective way to deliver inhalable medication. 

    Capsug...
  • VCAPS® ENTERIC CAPSULES

    Product VCAPS® ENTERIC CAPSULES

    Through the blend of polymer science and capsule engineering, Capsugel has developed a line of functional capsules that provides the industry with a viable alternative to achieve enteric protection and delayed release without functional (enteric) coating.

    Vcaps® Enteric Capsules is a capsule technology...

Lonza (Thailand) Co., Ltd. resources (1)

  • Brochure Vcaps Plus capsules

    Vcaps® Plus capsules developed without gelling agents provide HPMC capsules with improved physical and operational features to match the needs of the pharmaceutical industry.